文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中东地区皮肤利什曼病的流行情况:系统评价和荟萃分析。

Prevalence of cutaneous Leishmaniasis in the Middle East: a systematic review and meta-analysis.

机构信息

Department of Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.

Department of Biostatistics and Epidemiology, School of Health Science, Babol University of Medical Sciences, Babol, Iran.

出版信息

Pathog Glob Health. 2023 Jun;117(4):356-365. doi: 10.1080/20477724.2022.2133452. Epub 2022 Oct 12.


DOI:10.1080/20477724.2022.2133452
PMID:36222473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10177677/
Abstract

Cutaneous leishmaniasis (CL), caused by an obligate intracellular protozoan parasite from the genus Leishmania, imposing a significant burden on underdeveloped countries especially those located in the Middle East. Four electronic databases were searched to evaluate the prevalence of CL in the Middle East. The random effects model (95% confidence intervals (CI)) were applied to determine the overall and subgroup pooled prevalence. Heterogeneity was assessed by Cochran's Q test and I2 statistics. Among 2424 peer-reviewed papers, 37 datasets from 34 studies were included in the current meta-analysis. 285560 individuals were assessed across 9 Middle Eastern countries. The pooled prevalence of CL was estimated at 12% (95% CI 9-15 %; 10718/285560). The highest prevalence rate was observed in Syria (39%, 37-42%), and the lowest one was found in Iraq and Lebanon (0%, 0-1%). The prevalence of CL in studies that applied LST assays had the highest rate (48%, 17-80%). The infection rate in males was similar to females (7%, 4-10%). The prevalence of infection in individuals living in urban areas was higher than in rural areas (14%, 10-19%). The prevalence of CL in the age group 0-15 years was higher than in individuals 16-40 and >40 years (9%, 6-13%). Most of the lesions were found on the face, and single lesions were more prevalent than two and three ones. In conclusion, the occurrence of CL was considerable in Middle Eastern countries. Therefore, more efforts should be made to precisely report the CL in this region for developing appropriate preventive and controlling strategies.  .

摘要

皮肤利什曼病(CL)是由利什曼原虫属的专性细胞内原生动物寄生虫引起的,给欠发达国家,尤其是位于中东的国家带来了沉重负担。为了评估中东地区 CL 的流行情况,我们检索了四个电子数据库。采用随机效应模型(95%置信区间[CI])确定总体和亚组汇总流行率。采用 Cochran's Q 检验和 I2 统计评估异质性。在 2424 篇同行评议论文中,有 37 个数据集来自 34 项研究被纳入本次荟萃分析。共有 9 个中东国家的 285560 人参与评估。CL 的总流行率估计为 12%(95%CI 9-15%;10718/285560)。CL 的最高流行率见于叙利亚(39%,37-42%),最低见于伊拉克和黎巴嫩(0%,0-1%)。应用 LST 检测的研究中,CL 的流行率最高(48%,17-80%)。男性的感染率与女性相似(7%,4-10%)。居住在城市地区的个体感染率高于农村地区(14%,10-19%)。0-15 岁年龄组的感染流行率高于 16-40 岁和>40 岁年龄组(9%,6-13%)。大多数病变发生在面部,单发病变比两个和三个病变更为常见。总之,中东国家 CL 的发生率相当高。因此,应该更加努力地精确报告该地区的 CL 情况,以便制定适当的预防和控制策略。

相似文献

[1]
Prevalence of cutaneous Leishmaniasis in the Middle East: a systematic review and meta-analysis.

Pathog Glob Health. 2023-6

[2]
Cutaneous leishmaniasis in north Lebanon: re-emergence of an important neglected tropical disease.

Trans R Soc Trop Med Hyg. 2019-8-1

[3]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[4]
Parasitological and biochemical studies on cutaneous leishmaniasis in Shara'b District, Taiz, Yemen.

Ann Clin Microbiol Antimicrob. 2017-7-4

[5]
The new situation of cutaneous leishmaniasis after Syrian civil war in Gaziantep city, Southeastern region of Turkey.

Acta Trop. 2017-2

[6]
Prevalence of Leishmania RNA virus in Leishmania parasites in patients with tegumentary leishmaniasis: A systematic review and meta-analysis.

PLoS Negl Trop Dis. 2022-6

[7]
The increase in neglected cutaneous leishmaniasis in Gaziantep province of Turkey after mass human migration.

Acta Trop. 2019-4

[8]
Head and neck cutaneous leishmania: clinical characteristics, microscopic features and molecular analysis in a cohort of 168 cases.

Eur Arch Otorhinolaryngol. 2016-11

[9]
The Geographical Distribution of Cutaneous Leishmaniasis Causative Agents in Iran and Its Neighboring Countries, A Review.

Front Public Health. 2020-2-18

[10]
Clinical, parasitological and molecular profiles of Cutaneous Leishmaniasis and its associated factors among clinically suspected patients attending Borumeda Hospital, North-East Ethiopia.

PLoS Negl Trop Dis. 2020-8-25

引用本文的文献

[1]
Human Leishmaniasis in Algeria: A Systematic Review and Meta-Analysis.

Acta Parasitol. 2025-7-8

[2]
Comparative Analysis of Microscopy, Leishmanin Skin Test (LST), and Direct Agglutination Test (DAT) for the Diagnosis of Human Cutaneous Leishmaniasis.

Iran J Parasitol. 2025

[3]
Transcriptional alterations of virulence factors in Leishmania major clinical isolates harboring Leishmania RNA virus 2 (LRV2).

BMC Infect Dis. 2025-3-6

[4]
From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization.

Front Public Health. 2024

[5]
First report of Leishmania tropica in domestic and wild animal hosts in hyperendemic areas of human cutaneous leishmaniasis in western Yemen: a neglected tropical disease needing One Health approach.

Parasitol Res. 2024-6-27

[6]
Knowledge, attitude, practices and treatment-seeking behaviour concerning cutaneous leishmaniasis among rural hyperendemic communities in western Yemen.

Sci Rep. 2024-6-3

[7]
Clinical and laboratory characterization of cutaneous leishmaniasis in Chinese migrant workers returned from Iraq.

PLoS Negl Trop Dis. 2024-3

本文引用的文献

[1]
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).

Front Cell Infect Microbiol. 2021

[2]
A Retrospective Study of Cutaneous and Visceral Leishmaniasis in Istanbul, Turkey.

J Infect Dev Ctries. 2021-4-30

[3]
Emerging of Cutaneous Leishmaniais Due to in a New Focus in Esfahan Province, Central Iran.

J Arthropod Borne Dis. 2020-6-30

[4]
Cutaneous leishmaniasis: A neglected disfiguring disease for women.

Int J Womens Dermatol. 2019-2-10

[5]
Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees.

Clin Microbiol Infect. 2019-7-5

[6]
Review of Leishmaniasis in the Middle East and North Africa.

Afr Health Sci. 2019-3

[7]
Prevalence of Cutaneous Leishmaniasis in Western Highlands in Yemen.

J Trop Med. 2019-2-28

[8]
Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: Clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis.

Transbound Emerg Dis. 2019-4-15

[9]
Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates.

PLoS Negl Trop Dis. 2019-2-25

[10]
Cutaneous leishmaniasis in Qasr-e Shirin, a border area in the west of Iran.

Vet World. 2018-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索